表紙:変形性関節症の世界市場 (IA注射剤・NSAIDs・鎮痛剤):考察・動向・予測(2022-2026年)
市場調査レポート
商品コード
1072725

変形性関節症の世界市場 (IA注射剤・NSAIDs・鎮痛剤):考察・動向・予測(2022-2026年)

Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 95 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.51円
変形性関節症の世界市場 (IA注射剤・NSAIDs・鎮痛剤):考察・動向・予測(2022-2026年)
出版日: 2022年05月03日
発行: Koncept Analytics
ページ情報: 英文 95 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の変形性関節症の市場規模は予測期間中9.84%のCAGRで推移し、2026年には収益で121億4,000万米ドルの規模に成長すると予測されています。

変形性関節症の発生率の増加、老年人口の増加、1人当たりの医療費の増加、肥満人口の増加、消費者信頼感指数の改善などの要因が同市場の成長の原動力になると予想されています。一方で、ビジネス上のリスク、患者の健康に関連するリスク、厳しい規制などが同市場の成長に影響を及ぼすと考えられています。

地域別では、北米地域がもっとも高い成長率を示しています。老年人口の増加、HA注射の需要の急増、スポーツ障害の増加、Eコマース産業の発展などがこの成長を支えています。

当レポートでは、世界の変形性関節症の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、主要企業のプロファイルなどをまとめています。

目次

第1章 市場概要

  • 原因
  • 症状
  • 診断
  • 治療

第2章 世界の変形性関節症市場の分析

  • 世界の変形性関節症の市場規模
  • 世界の変形性関節症の市場規模予測
  • 世界の変形性関節症の市場規模・予測:部位別
    • 変形性膝関節症
    • 変形性膝関節症:地域別
  • 世界の変形性関節症の市場規模・予測:治療タイプ別
    • IA注射剤
    • 変形性関節症治療薬
    • 変形性関節症治療薬:タイプ別
    • NSAIDs
    • 鎮痛剤
    • 変形性関節症治療薬:投与経路別
    • 非経口薬
    • 経口薬
  • 世界の変形性関節症の市場規模・予測:流通経路別
  • 世界の変形性関節症の市場規模・予測:地域別

第3章 変形性関節症市場の分析:地域別

  • 北米
  • 欧州
  • アジア太平洋

第4章 市場力学

  • 成長要因
  • 主な動向・展開
  • 課題

第5章 企業プロファイル

  • Johnson & Johnson
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi S.A.
図表

List of Figures

  • Global Osteoarthritis Market Value (2017-2021)
  • Global Osteoarthritis Market Value Forecast (2022-2026)
  • Global Osteoarthritis Market Value by Anatomy Type (2021)
  • Global Knee Osteoarthritis Market Value (2017-2021)
  • Global Knee Osteoarthritis Market Value Forecast (2022-2026)
  • Global Knee Osteoarthritis Market Value by Region (2021)
  • Global Osteoarthritis Market Value by Treatment Type (2021)
  • Global Osteoarthritis IA Injections Market Value (2017-2021)
  • Global Osteoarthritis IA Injections Market Value Forecast (2022-2026)
  • Global Osteoarthritis Drugs Market Value (2017-2021)
  • Global Osteoarthritis Drugs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Drugs Market Value by Type (2021)
  • Global Osteoarthritis NSAIDs Market Value (2017-2021)
  • Global Osteoarthritis NSAIDs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Analgesics Market Value (2017-2021)
  • Global Osteoarthritis Analgesics Market Value Forecast (2022-2026)
  • Global Osteoarthritis Drugs Market Value by Route of Administration (2021)
  • Global Osteoarthritis Parenteral Drugs Market Value (2017-2021)
  • Global Osteoarthritis Parenteral Drugs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Oral Drugs Market Value (2017-2021)
  • Global Osteoarthritis Oral Drugs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Market Value by Distribution Channels (2020)
  • Global Osteoarthritis Market Value by Region (2021)
  • North America Osteoarthritis Market Value (2017-2021)
  • North America Osteoarthritis Market Value Forecast (2022-2026)
  • North America Osteoarthritis Market Value by Anatomy Type (2021)
  • North America Knee Osteoarthritis Market Value (2017-2021)
  • North America Osteoarthritis Market Value Forecast (2022-2026)
  • North America Osteoarthritis Market Value by Country (2020)
  • The U.S. Osteoarthritis Market Value (2017-2021)
  • The U.S. Osteoarthritis Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Market Value by Treatment Type (2021)
  • The U.S. Osteoarthritis IA Injections Market Value (2017-2021)
  • The U.S. Osteoarthritis IA Injections Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Drugs Market Value (2017-2021)
  • The U.S. Osteoarthritis Drugs Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Drugs Market Value by Type (2021)
  • The U.S. Osteoarthritis NSAIDs Market Value (2017-2021)
  • The U.S. Osteoarthritis NSAIDs Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Analgesics Market Value (2017-2021)
  • The U.S. Osteoarthritis Analgesics Market Value Forecast (2022-2026)
  • Europe Osteoarthritis Market Value (2017-2021)
  • Europe Osteoarthritis Market Value Forecast (2022-2026)
  • Europe Osteoarthritis Market Value by Anatomy Type (2021)
  • Europe Knee Osteoarthritis Market Value (2017-2021)
  • Europe Knee Osteoarthritis Market Value Forecast (2022-2026)
  • Asia-Pacific Osteoarthritis Market Value (2017-2021)
  • Asia-Pacific Osteoarthritis Market Value Forecast (2022-2026)
  • Asia-Pacific Osteoarthritis Market Value by Anatomy Type (2021)
  • Asia-Pacific Knee Osteoarthritis Market Value (2017-2021)
  • Asia-Pacific Knee Osteoarthritis Market Value Forecast (2022-2026)
  • Global Osteoarthritis Population (2017-2021)
  • Global Geriatric Population (2017-2021)
  • Global Healthcare Expenditure per Capita (2017-2021)
  • The U.S. Obese Population (2017-2021)
  • Consumer Confidence Index in US and Europe (2017-2021)
  • Global Pharmaceutical R&D Expenditures (2017-2021)
  • Global Online Pharmaceutical Sales (2022-2026)
目次

The global osteoarthritis market revenues are forecasted to touch US$12.14 billion in 2026, growing at a CAGR of 9.84% for the period spanning 2022 to 2026.

Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.

The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels.

Scope of the report:

  • The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.

Key Target Audience:

  • Osteoarthritis Therapeutics Manufacturers
  • Ingredient Suppliers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Causes
  • 1.3 Symptoms
  • 1.4 Diagnosis
  • 1.5 Treatment

2. Global Osteoarthritis Market Analysis

  • 2.1 Global Osteoarthritis Market Value
  • 2.2 Global Osteoarthritis Market Value Forecast
  • 2.3 Global Osteoarthritis Market Value by Anatomy Type
    • 2.3.1 Global Knee Osteoarthritis Market Value
    • 2.3.2 Global Knee Osteoarthritis Market Value Forecast
    • 2.3.3 Global Knee Osteoarthritis Market Value by Region
  • 2.4 Global Osteoarthritis Market Value by Treatment Type
    • 2.4.1 Global Osteoarthritis IA Injections Market Value
    • 2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
    • 2.4.3 Global Osteoarthritis Drugs Market Value
    • 2.4.4 Global Osteoarthritis Drugs Market Value Forecast
    • 2.4.5 Global Osteoarthritis Drugs Market Value by Type
    • 2.4.6 Global Osteoarthritis NSAIDs Market Value
    • 2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
    • 2.4.8 Global Osteoarthritis Analgesics Market Value
    • 2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
    • 2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
    • 2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
    • 2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
    • 2.4.13 Global Osteoarthritis Oral Drugs Market Value
    • 2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
  • 2.5 Global Osteoarthritis Market Value by Distribution Channels
  • 2.6 Global Osteoarthritis Market Value by Region

3. Regional Osteoarthritis Market Analysis

  • 3.1 North America
    • 3.1.1 North America Osteoarthritis Market Value
    • 3.1.2 North America Osteoarthritis Market Value Forecast
    • 3.1.3 North America Osteoarthritis Market Value by Anatomy Type
    • 3.1.4 North America Knee Osteoarthritis Market Value
    • 3.1.5 North America Knee Osteoarthritis Market Value Forecast
    • 3.1.6 North America Osteoarthritis Market Value by Country
    • 3.1.7 The U.S. Osteoarthritis Market Value
    • 3.1.8 The U.S. Osteoarthritis Market Value Forecast
    • 3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type
    • 3.1.10 The U.S. Osteoarthritis IA Injections Market Value
    • 3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast
    • 3.1.12 The U.S. Osteoarthritis Drugs Market Value
    • 3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast
    • 3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type
    • 3.1.15 The U.S. Osteoarthritis NSAIDs Market Value
    • 3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast
    • 3.1.17 The U.S. Osteoarthritis Analgesics Market Value
    • 3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast
  • 3.2 Europe
    • 3.2.1 Europe Osteoarthritis Market Value
    • 3.2.2 Europe Osteoarthritis Market Value Forecast
    • 3.2.3 Europe Osteoarthritis Market Value by Anatomy Type
    • 3.2.4 Europe Knee Osteoarthritis Market Value
    • 3.2.5 Europe Knee Osteoarthritis Market Value Forecast
  • 3.3 Asia-Pacific
    • 3.3.1 Asia-Pacific Osteoarthritis Market Value
    • 3.3.2 Asia-Pacific Osteoarthritis Market Value Forecast
    • 3.3.3 Asia-Pacific Osteoarthritis Market Value by Anatomy Type
    • 3.3.4 Asia-Pacific Knee Osteoarthritis Market Value
    • 3.3.5 Asia-Pacific Knee Osteoarthritis Market Value Forecast

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Inclining Occurrence of Osteoarthritis
    • 4.1.2 Growing Geriatric Population
    • 4.1.3 Rising Healthcare Expenditure per Capita
    • 4.1.4 Growing Obese Population
    • 4.1.5 Improving Consumer Confidence Index
  • 4.2 Key Trends and Developments
    • 4.2.1 Growth in Pharmaceutical R&D Expenditures
    • 4.2.2 Progressing Product Pipeline
    • 4.2.3 Advancement in Osteoarthritis Treatments
    • 4.2.4 Growth in Online Pharmaceutical Sales
  • 4.3 Challenges
    • 4.3.1 Associated Business Risk
    • 4.3.2 Patient Health-Associated Risk
    • 4.3.3 Stringent Regulations

5. Company Profiles

  • 5.1 Johnson & Johnson
    • 5.1.1 Business Overview
  • 5.2 Novartis AG
    • 5.2.1 Business Overview
  • 5.3 Bayer AG
    • 5.3.1 Business Overview
  • 5.4 GlaxoSmithKline Plc
    • 5.4.1 Business Overview
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
  • 5.6 Sanofi S.A.
    • 5.6.1 Business Overview